Clonazepam for refractory headache: Three cases illustrative of benefit and risk

Headache

Volumn 50, Issue 4, 2010, Pages 650-656

  Maizels, Morris ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

Chronic migraine; Clonazepam; Prophylaxis; Psychiatric comorbidity; Refractory headache

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIMIGRAINE AGENT; BOTULINUM TOXIN; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CLONAZEPAM; DEXAMETHASONE; DIAZEPAM; FLUOXETINE; GABAPENTIN; HYDROCODONE; IMIPRAMINE; MELOXICAM; NARATRIPTAN; NORTRIPTYLINE; OPIATE; PROPRANOLOL; RIZATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANAMNESIS; ANXIETY DISORDER; BEDTIME DOSAGE; CASE REPORT; CHRONIC TENSION HEADACHE; CLINICAL EXAMINATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG OVERDOSE; DRUG WITHDRAWAL; DYSTHYMIA; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MALE; MIGRAINE; MIGRAINE WITH AURA; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK BENEFIT ANALYSIS;

ADULT; ANXIETY DISORDERS; CLONAZEPAM; COMORBIDITY; DEPRESSIVE DISORDER; DRUG TOLERANCE; FEMALE; GABA MODULATORS; HUMANS; MALE; MIGRAINE DISORDERS; MOOD DISORDERS; RISK ASSESSMENT; SUBSTANCE-RELATED DISORDERS;

EID: 77950525462     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01633.x     Document Type: Review

References (27)

1. Radat F, Swendsen J. Psychiatric comorbidity in migraine: A review. Cephalalgia. 2005 25 : 165 178.
2. Silberstein SD for the US Headache Consortium. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Neurology. 2000 55 : 754 763.
3. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009 25 : 446 452.
4. Penzien DB, Rains JC, McGrath PJ. Psychological and behavioral treatments of migraine. In : Olesen J, Goadsby P, Radamadan N, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn.
5. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology. 2003 60 : 1308 1312.
6. Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KMA. Headache types and panic disorders: Directionality and specificity. Neurology. 2001 56 : 350 354.
7. Lanteri-Minet M, Radat F, Chautard M-H, Lucas C. Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005 118 : 319 326.
8. Tomkins G, Jackson J, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: A meta-analysis. Am J Med. 2001 111 : 54 63.
9. Cohen LS, Rosenbaum JF. Clonazepam: New uses and potential problems. J Clin Psychiatry. 1987 48 (10 Suppl. 50 55.
10. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff R-S. Clonazepam open clinical treatment trial for myofascial syndrome associated chronic pain. Pain Medicine. 2000 1 : 332 339.
11. Stensrud P, Sjaastad O. Clonazepam (Rivotril) in Migraine Prophylaxis. Headache. 1979 19 : 333 334.
12. Paiva T, Nunes JS, Moreira A, et al. Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache. 1982 22 : 216 220.
13. Shukla R, Nag D, Ahuja RC. Alprazolam in chronic tension-type headache. J Assoc Physicians India. 1996 44 : 641 644.
14. Takebayashi M, Fujikawa T, Kagaya A, Horiguchi J, Yamawaki S. Lithium and clonazepam treatment of two cases with cluster headache. Psychiatry Clin Neurosci. 1999 53 : 535 537.
15. Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: A double-blind pilot study. J Craniomandib Disord. 1991 5 : 179 186.
16. Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: A randomized clinical trial. J Orofac Pain. 2002 16 : 64 70.
17. Swerdlow M, Cundill JG. Anticonvulsant drugs used in the treatment of lancinating pain. A comparison. Anaesthesia. 1981 36 : 1129 1132.
18. Buckoms AJ, Litman RE. Clonazepam in the treatment of neuralgic pain syndrome. Psychosomatics. 1985 26 : 933 936.
19. Moroz G, Rosenbaum GF. Efficacy, safety and gradual discontinuation of clonazepam in panic disorder: A placebo-controlled controlled multicenter study using optimized dosages. J Clin Psychiatry. 1999 60 : 604 612.
20. Reddy S, Patt RB. The benzodiazepines as adjuvant analgesics. J Pain Symptom Manage. 1994 9 : 510 514.
21. Hugel H, Ellershaw JE, Dicman A. Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain. J Pain Symptom Manage. 2003 26 : 1073 1074 (Letter).
22. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs. 2003 17 : 85 100.
23. Baloh RW. Migraine and vertigo: Epidemiology, genetics, and mechanism(s). Headache Curr. 2006 3 : 1 7.
24. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified? Eur Neuropsychopharmacol. 1999 9 (Suppl. 6 S399 S405.
25. Ciccone DS, Just N, Bandilla EB, Reimer E, Ilbeigi MS, Wu W. Psychological correlates of opioid use in patients with chronic nonmalignant pain: A preliminary test of the downhill spiral hypothesis. J Pain Symptom Manage. 2000 20 : 180 192.
26. Nardi AE, Perna G. Clonazepam in the treatment of psychiatric disorders: An update. Int Clin Psychopharmacol. 2006 21 : 131 142.
27. Soumerai SB, Simoni-Wastila L, Singer C, et al. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv. 2003 54 : 1006 1011.